Journal Information
Vol. 89. Issue 3.
Pages 278-285 (May - June 2013)
Share
Share
Download PDF
More article options
Vol. 89. Issue 3.
Pages 278-285 (May - June 2013)
ARTIGO ORIGINAL
Open Access
Molecular characterization of rotavirus genotypes in immunosuppressed and non-immunosuppressed pediatric patients
Caracterização molecular dos genótipos do rotavírus em pacientes pediátricos imunossuprimidos e não imunossuprimidos
Visits
4680
Luciane A. Pereiraa, Carla E.O. Ferreiraa, Giovana D. Turchettob, Meri B. Nogueirab, Luine R. Vidalb, Cristina R. Cruzc, Maria C. Deburd, Sergio M. De Almeidae, Sonia M. Rabonif,
Corresponding author
sraboni@ufpr.br

Corresponding author.
a Bióloga, Laboratório de Virologia, Universidade Federal do Paraná (UFPR), Curitiba, PR, Brasil
b Bioquímica, Laboratório de Virologia, UFPR, Curitiba, PR, Brasil
c Professora, Departamento de Pediatria, UFPR, Curitiba, PR, Brasil
d Bioquímica, Laboratório de Saúde Pública do Estado, Secretaria Estadual de Saúde do Paraná, Curitiba, PR, Brasil
e Médico, Laboratório de Virologia, UFPR, Curitiba, PR, Brasil
f Professora-associada, Laboratório de Virologia e Departamento de Doenças Infecciosas, UFPR, Curitiba, PR, Brasil
This item has received

Under a Creative Commons license
Article information
Abstract
Objective

To describe the genotypic variability of group A rotavirus (RVA) found in immunosuppressed and non-immunosuppressed pediatric patients treated at the Hospital de Clínicas da Universidade Federal do Paraná (HC-UFPR), Curitiba, Paraná.

Methods

A cross-sectional study was conducted with 1,140 stool samples collected from April, 2001 to December, 2008 in outpatients and hospitalized patients with acute gastroenteritis referred to the hospital. RVA diagnosis was performed through the latex agglutination method and enzyme immunoassay. Reverse transcription followed by multiplex hemi-nested polymerase chain reaction (PCR) and nucleotide sequencing were used for genotype characterization. Genotype combinations, clinical data, epidemiological data, laboratory data, and presence of hospital-acquired infections were reported.

Results

A total of 80 rotavirus-positive stool samples were analyzed. The most frequent associations between genotypes G and P were: G4 P[8] (38.9%), G1 P[8] (30.5%), G9 P[8] (13.9%), G2 P[4] (6.9%), and G3 P[8] (1.4%). G2 P[4] was the most prevalent genotype after the vaccine implementation in the years 2006 and 2008. A total of 62.5% of children aged less than 12 months were found to be infected. Of these, 55.6% had severe dehydration and 26.7% needed intensive care. A frequency of 12.5% of nosocomial infections was found. No correlation was observed between genotype and severity of infection in the study patients.

Conclusion

RVA infections can be associated with severe clinical manifestations, and the surveillance of genotypic variability of this virus is crucial to monitor the emergence of new strains and the impact of the immunization in these patients.

Keywords:
Gastroenteritis
Genotypes
Pediatric infections
Rotavirus
Resumo
Objetivo

Descrever a variabilidade genotípica do rotavírus grupo A (RVA) encontrado em pacientes pediátricos imunocompetentes e imunocomprometidos tratados no Hospital de Clínicas/Universidade Federal do Paraná (HC/UFPR), Curitiba, Paraná.

Métodos

Foi realizado um estudo transversal com 1.140 amostras de fezes coletadas, de abril de 2001 a dezembro de 2008, em pacientes ambulatoriais e pacientes hospita- lizados com gastroenterite aguda encaminhados ao hospital. As técnicas usadas foram o método da aglutinação do látex e imunoensaio enzimático para diagnóstico de RVA. Foi realizada transcrição reversa, seguida por PCR multiplex semi-nested e sequência de nucleotídeos para caracterização do genótipo. Foram relatados dados de combinações de genótipos, clínicos, epidemiológicos, laboratoriais e sobre a presença de infecções hospitalares.

Resultados

Foi analisado um total de 80 amostras de fezes positivas para rotavírus. As associações mais frequentes entre os genótipos G e P foram: G4 P[8] (38,9%), G1 P[8] (30,5%), G9 P[8] (13,9%), G2 P[4] (6.9%) e G3 P[8] 1,4%). O genótipo prevalente foi G2 P[4] depois da implementação da vacina nos anos de 2006 e 2008. Verificou-se que um total de 62,5% das crianças com idade abaixo de 12 meses estavam infectadas. Destas, 55,6% tinham grave desidratação, e 26,7% precisaram de cuidados intensivos. Encontrou- se uma frequência de 12,5% de infecções hospitalares. Não se observou correlação entre o genótipo e a gravidade da infecção nos pacientes estudados.

Conclusão

As infecções por RVA podem associar-se a manifestações clínicas graves e é crucial a vigilância da variabilidade genotípica desse vírus para monitorizar a emergência de novas cepas e o impacto da imunização nesses pacientes.

Palavras chave:
Gastroenterite
Genótipos
Infecções pediátricas
Rotavírus
Full text is only aviable in PDF
Referências
[1]
U.D. Parashar, C.J. Gibson, J.S. Bresee, R.I. Glass.
Rotavirus and severe childhood diarrhea.
Emerg Infect Dis., 12 (2006), pp. 304-306
[2]
S. Ramani, M. Iturriza-Gomara, A.K. Jana, K.A. Kuruvilla, J.J. Gray, D.W. Brown, et al.
Whole genome characterization of reassortant G10P[11] strain (N155) from a neonate with symptomatic rotavirus infection: identification of genes of human and animal rotavirus origin.
J Clin Virol., 45 (2009), pp. 237-244
[3]
F.A. Carvalho-Costa, E.M. Volotão de, R.M. de Assis, A.M. Fialho, J.S. de Andrade da, L.N. Rocha, et al.
Laboratory-based rotavirus surveillance during the introduction of a vaccination program, Brazil, 2005–2009.
Pediatr Infect Dis J., 30 (2011), pp. S35-S41
[4]
A.C. Linhares.
Rotavirus infection in Brazil: epidemiology and challenges for its control.
Cad Saude Publica, 16 (2000), pp. 629-646
[5]
S.M. Raboni, M.B. Nogueira, V.M. Hakim, V.T. Torrecilha, H. Lerner, L.R. Tsuchiya.
Comparison of latex agglutination with enzyme immunoassay for detection of rotavirus in fecal specimens.
Am J Clin Pathol., 117 (2002), pp. 392-394
[6]
B.A. Lopman, D.C. Payne, J.E. Tate, M.M. Patel, M.M. Cortese, U.D. Parashar.
Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011.
Curr Opin Virol., 2 (2012), pp. 434-442
[7]
K. Soares-Weiser, H. Maclehose, H. Bergman, I. Ben-Aharon, S. Nagpal, E. Goldberg, et al.
Vaccines for preventing rotavirus diarrhoea: vaccines in use.
Cochrane Database Syst Rev., 2 (2012), pp. CD008521
[8]
Brasil. Ministério da Saúde. Saúde Brasil 2008: 20 anos do Sistema Único de Saúde (SUS) no Brasil. Brasília: Ministério da Saúde; 2009. 416p
[9]
T.M. Lanzieri, I. Costa, F.A. Shafi, M.H. Cunha, E. Ortega-Barria, A.C. Linhares, et al.
Trends in hospitalizations from all-cause gastroenteritis in children younger than 5 years of age in Brazil before and after human rotavirus vaccine introduction, 1998–2007.
Pediatr Infect Dis J., 29 (2010), pp. 673-675
[10]
N. Santos, Y. Hoshino.
Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine.
Rev Med Virol., 15 (2005), pp. 29-56
[11]
M.H. Gorelick, K.N. Shaw, K.O. Murphy.
Validity and reliability of clinical signs in the diagnosis of dehydration in children.
Pediatrics., 99 (1997), pp. E6
[12]
L.A. Pereira, S.M. Raboni, M.B. Nogueira, L.R. Vidal, S.M. Almeida, M.C. Debur, et al.
Rotavirus infection in a tertiary hospital: laboratory diagnosis and impact of immunization on pediatric hospitalization.
Braz J Infect Dis., 15 (2011), pp. 215-219
[13]
J.S. Santos, A.F. Alfieri, J.P. Leite, I. Skraba, A.A. Alfieri.
Molecular epidemiology of the human group A rotavirus in the Paraná State, Brazil.
Braz Arch Biol Technol., 51 (2008), pp. 287-294
[14]
T.A. Hall.
BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT.
Nucl Acids Symp Ser., 41 (1999), pp. 95-98
[15]
National Center for Biotechnology Information [Internet]. Bethesda (MD): U.S. National Library of Medicine [acessado em 27 Nov 2011]. GenBank. Disponível em: http://www.ncbi.nlm. nih.gov/
[16]
N. Coluchi, V. Munford, J. Manzur, C. Vazquez, M. Escobar, E. Weber, et al.
Detection, subgroup specificity, and genotype diversity of rotavirus strains in children with acute diarrhea in Paraguay.
J Clin Microbiol., 40 (2002), pp. 1709-1714
[17]
R.C. Carmona, M.C. Timenetsky do, S.G. Morillo, L.J. Richtzenhain.
Human rotavirus serotype G9, São Paulo, Brazil, 1996–2003.
Emerg Infect Dis., 12 (2006), pp. 963-968
[18]
Ferrera A, Quan D, Espinoza F. Increased prevalence of genotype G2P(4) among children with rotavirus-associated gastroenteritis in Honduras. 17th European Congress of Clinical Microbiology and Infectious Diseases ICC; 2007 Mar 31-Apr 04; Munich. Hoboken (NJ): Wiley-Blackwell; 2007
[19]
A. Cilli, A. Luchs, S.G. Morillo, F.F. Costa, R.C. Carmona de, M.C. Timenetsky do.
Characterization of rotavirus and norovirus strains: a 6-year study (2004-2009).
J Pediatr (Rio J)., 87 (2011), pp. 445-449
[20]
F.A. Carvalho-Costa, R.M. Assis, A.M. Fialho, M.N. Bóia, D.P. Alves, C.M. Martins, et al.
Detection and molecular characterization of group A rotavirus from hospitalized children in Rio de Janeiro, Brazil, 2004.
Mem Inst Oswaldo Cruz., 101 (2006), pp. 291-294
[21]
C.D. Kirkwood, K. Boniface, G.L. Barnes, R.F. Bishop.
Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia.
Pediatr Infect Dis J., 30 (2011), pp. S48-S53
[22]
M.M. Patel, L.H. de Oliveira, A.M. Bispo, J. Gentsch, U.D. Parashar.
Rotavirus P[4]G2 in a vaccinated population.
Brazil. Emerg Infect Dis., 14 (2008), pp. 863-865
[23]
M.A. Sáfadi, E.N. Berezin, V. Munford, F.J. Almeida, J.C. de Moraes, C.F. Pinheiro, et al.
Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo.
Brazil. Pediatr Infect Dis J., 29 (2010), pp. 1019-1022
[24]
E.M. Kane, R.M. Turcios, M.L. Arvay, S. Garcia, J.S. Bresee, R.I. Glass.
The epidemiology of rotavirus diarrhea in Latin America. Anticipating rotavirus vaccines.
Rev Panam Salud Publica., 16 (2004), pp. 371-377
[25]
A.A. Nunes, L.M. de Mello, R.N. Parrode, J.P. Bittar, A.L. Domingues.
Prevalence of rotavirus in acute diarrhea and its association with clinical signs and symptoms.
J Trop Pediatr., 56 (2010), pp. 212-213
[26]
M.S. Andreasi, S.M. Batista, I.A. Tozetti, C.O. Ozaki, M.M. Nogueira, F.S. Fiaccadori, Rotavirus A, et al.
among hospitalized infants, up to three years of age, with acute gastroenteritis in Campo Grande, State of Mato Grosso do Sul.
Rev Soc Bras Med Trop., 40 (2007), pp. 411-414
[27]
M.L. Silva, J.R. Souza, M.M. Melo.
Rotavirus prevalence in infants and children in the public healthcare system of the state of Pernambuco.
Rev Soc Bras Med Trop., 43 (2010), pp. 548-551
[28]
C. Aupiais, A. de Rougemont, C. Menager, C. Vallet, J.F. Brasme, J. Kaplon, et al.
Severity of acute gastroenteritis in infants infected by G1 or G9 rotaviruses.
J Clin Virol., 46 (2009), pp. 282-285
[29]
M. Harrington, K. Butler, M. Cafferkey.
Rotavirus infection in hospitalised children: incidence and impact on healthcare resources.
Ir J Med Sci., 172 (2003), pp. 33-36
[30]
P. Gianino, E. Mastretta, P. Longo, A. Laccisaglia, M. Sartore, R. Russo, et al.
Incidence of nosocomial rotavirus infections, symptomatic and asymptomatic, in breast-fed and non-breast- fed infants.
J Hosp Infect., 50 (2002), pp. 13-17
[31]
O. Gleizes, U. Desselberger, V. Tatochenko, C. Rodrigo, N. Salman, Z. Mezner, et al.
Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease.
Pediatr Infect Dis J., 25 (2006), pp. S12-S21

Como citar este artigo: Pereira LA, Ferreira CE, Turchetto GD, Nogueira MB, Vidal LR, Cruz CR, et al. Molecular characterization of rotavirus genotypes in immunosuppressed and non-immunosuppressed pediatric patients. J Pediatr (Rio J). 2013;89:278-85.

Copyright © 2013. Sociedade Brasileira de Pediatria
Download PDF
Idiomas
Jornal de Pediatria (English Edition)
Article options
Tools
en pt
Taxa de publicaçao Publication fee
Os artigos submetidos a partir de 1º de setembro de 2018, que forem aceitos para publicação no Jornal de Pediatria, estarão sujeitos a uma taxa para que tenham sua publicação garantida. O artigo aceito somente será publicado após a comprovação do pagamento da taxa de publicação. Ao submeterem o manuscrito a este jornal, os autores concordam com esses termos. A submissão dos manuscritos continua gratuita. Para mais informações, contate assessoria@jped.com.br. Articles submitted as of September 1, 2018, which are accepted for publication in the Jornal de Pediatria, will be subject to a fee to have their publication guaranteed. The accepted article will only be published after proof of the publication fee payment. By submitting the manuscript to this journal, the authors agree to these terms. Manuscript submission remains free of charge. For more information, contact assessoria@jped.com.br.
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.